These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36317631)

  • 1. Deciphering the enigma of neuroendocrine prostate cancer.
    Karzai F; Madan RA
    J Clin Invest; 2022 Nov; 132(21):. PubMed ID: 36317631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential.
    Masumori N; Thomas TZ; Chaurand P; Case T; Paul M; Kasper S; Caprioli RM; Tsukamoto T; Shappell SB; Matusik RJ
    Cancer Res; 2001 Mar; 61(5):2239-49. PubMed ID: 11280793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current and emerging therapies for neuroendocrine prostate cancer.
    Alabi BR; Liu S; Stoyanova T
    Pharmacol Ther; 2022 Oct; 238():108255. PubMed ID: 35905791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression of prostate cancer to neuroendocrine cell tumor.
    Tanaka M; Suzuki Y; Takaoka K; Suzuki N; Murakami S; Matsuzaki O; Shimazaki J
    Int J Urol; 2001 Aug; 8(8):431-6; discussion 437. PubMed ID: 11555007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuroendocrine differentiation in adenocarcinoma of the prostate with progression of disease during hormonal treatment: a report of two cases].
    Kosugi M; Hanawa Y; Momma T; Saito S; Hirose S
    Nihon Hinyokika Gakkai Zasshi; 2003 May; 94(4):521-4. PubMed ID: 12795167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and Biological Features of Neuroendocrine Prostate Cancer.
    Yamada Y; Beltran H
    Curr Oncol Rep; 2021 Jan; 23(2):15. PubMed ID: 33433737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-1β promotes skeletal colonization and progression of metastatic prostate cancer cells with neuroendocrine features.
    Liu Q; Russell MR; Shahriari K; Jernigan DL; Lioni MI; Garcia FU; Fatatis A
    Cancer Res; 2013 Jun; 73(11):3297-305. PubMed ID: 23536554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuroendocrine differentiation in adenocarcinoma of the prostate during hormonal treatment: a case report].
    Matsumoto Y; Mibu H; Kagebayashi Y
    Hinyokika Kiyo; 2004 Nov; 50(11):813-5. PubMed ID: 15628545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large-cell neuroendocrine carcinoma of prostate. Case report.
    Moratalla Charcos LM; Pastor Navarro T; Cortes Vizcaino V; Osca Garcia JM; Gil Salom M
    Arch Esp Urol; 2013 May; 66(4):368-71. PubMed ID: 23676541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD44 expression is a feature of prostatic small cell carcinoma and distinguishes it from its mimickers.
    Simon RA; di Sant'Agnese PA; Huang LS; Xu H; Yao JL; Yang Q; Liang S; Liu J; Yu R; Cheng L; Oh WK; Palapattu GS; Wei J; Huang J
    Hum Pathol; 2009 Feb; 40(2):252-8. PubMed ID: 18835619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of neuroendocrine acquisition and biomarker expression between neuroendocrine and usual prostatic carcinoma.
    Xiao GQ; Ho G; Suen C; Hurth KM
    Prostate; 2021 Jun; 81(8):469-477. PubMed ID: 33848377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroendocrine Tumors of the Prostate: Emerging Insights from Molecular Data and Updates to the 2016 World Health Organization Classification.
    Priemer DS; Montironi R; Wang L; Williamson SR; Lopez-Beltran A; Cheng L
    Endocr Pathol; 2016 Jun; 27(2):123-35. PubMed ID: 26885643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-serum prostate-specific antigen level predicts poor outcomes in patients with primary neuroendocrine prostate cancer.
    Wang J; Xu W; Mierxiati A; Huang Y; Wei Y; Lin G; Dai B; Freedland SJ; Qin X; Zhu Y; Ye DW
    Prostate; 2019 Sep; 79(13):1563-1571. PubMed ID: 31376193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucin-secreting adenocarcinoma of the prostate with neuroendocrine differentiation and Paneth-like cells.
    Van de Voorde W; Van Poppel H; Haustermans K; Baert L; Lauweryns J
    Am J Surg Pathol; 1994 Feb; 18(2):200-7. PubMed ID: 8291659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy with atezolizumab for small cell or neuroendocrine carcinoma of the prostate: A single institution experience.
    Wee CE; Costello BA; Orme JJ; Quevedo JF; Pagliaro LC
    Prostate; 2021 Sep; 81(13):938-943. PubMed ID: 34254332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation and clinical value of neuroendocrine differentiation in human prostatic tumors.
    Cussenot O; Villette JM; Cochand-Priollet B; Berthon P
    Prostate Suppl; 1998; 8():43-51. PubMed ID: 9690663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neuroendocrine differentiation in adenocarcinoma of prostate during combined androgen blockade therapy: a case report].
    Kitamoto K; Hayashi T; Tamada S; Ezaki K; Kawashima H; Sugimura K; Nakatani T
    Hinyokika Kiyo; 2005 Jan; 51(1):33-5. PubMed ID: 15732339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOXA1 inhibits prostate cancer neuroendocrine differentiation.
    Kim J; Jin H; Zhao JC; Yang YA; Li Y; Yang X; Dong X; Yu J
    Oncogene; 2017 Jul; 36(28):4072-4080. PubMed ID: 28319070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reporting Trends, Practices, and Resource Utilization in Neuroendocrine Tumors of the Prostate Gland: A Survey among Thirty-Nine Genitourinary Pathologists.
    Mohanty SK; Lobo A; Williamson SR; Shah RB; Trpkov K; Varma M; Sirohi D; Aron M; Kandukari SR; Balzer BL; Luthringer DL; Ro J; Osunkoya AO; Desai S; Menon S; Nigam LK; Sardana R; Roy P; Kaushal S; Midha D; Swain M; Ambekar A; Mitra S; Rao V; Soni S; Jain K; Diwaker P; Pattnaik N; Sharma S; Chakrabarti I; Sable M; Jain E; Jain D; Samra S; Vankalakunti M; Mohanty S; Parwani AV; Sancheti S; Kumari N; Jha S; Dixit M; Malik V; Arora S; Munjal G; Gopalan A; Magi-Galluzzi C; Dhillon J
    Int J Surg Pathol; 2023 Sep; 31(6):993-1005. PubMed ID: 35946087
    [No Abstract]   [Full Text] [Related]  

  • 20. Neuroendocrine prostate cancer xenografts with large-cell and small-cell features derived from a single patient's tumor: morphological, immunohistochemical, and gene expression profiles.
    Aparicio A; Tzelepi V; Araujo JC; Guo CC; Liang S; Troncoso P; Logothetis CJ; Navone NM; Maity SN
    Prostate; 2011 Jun; 71(8):846-56. PubMed ID: 21456067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.